Salute e Benessere

BioSenic reaches agreement on binding term sheets with main creditors to…

INSIDE INFORMATIONNew binding term sheets have been formulated upon for the replacement of the Monument and Patronale bonds and loans by new unsecured convertible bonds as well as for the long-term extension of the past loan financing with the European Investment Bank.Mont-Saint-Guibert, Belgium, September 14, 2023, 7.00 am CEST – BIOSENIC(Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy,...
Nasdaq GlobeNewswire
14/09/2023

Sequana Medical announces H1 2023 results and provides business update

PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 14 September 2023, 07:00 CEST alfapump® – strongpivotal POSEIDON data presented at leading international liver congress / on track to file Pre-Market Approval (PMA) application to US FDA in Q4 2023DSR®–safety of single dose DSR 2.0demonstrated /Phase 1/2a US MOJAVE study in heart failure ongoingwith initial...
Nasdaq GlobeNewswire
14/09/2023

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial…

FULCRUM-VT is set to enroll 20 patients across four investigational sites, including Banner - University Medical Center in Phoenix and three other world-renowned VT ablation programs: Vanderbilt University Hospital in Nashville, TN with Dr. William Stevenson, Mount Sinai Hospital, NY, with Dr. Vivek Reddy and University of California in San Francisco with Dr. Edward Gerstenfeld. The enrollment criteria of the trial include both ischemic and non-ischemic heart disease, implanted cardioverter…
PR Newswire
14/09/2023

Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses…

Key Takeaways from the Acute Lymphocytic Leukemia Market Report Key Takeaways from the Acute Lymphocytic Leukemia Market Report Discover which therapies are expected to grab the major acute lymphocytic leukemia market share @Acute Lymphocytic Leukemia Market Report Acute Lymphocytic Leukemia Overview Acute lymphocytic leukemia, also known as acute lymphoblastic leukemia, is a type of blood cancer that primarily affects the lymphocytes, a type of white blood cell. This...
PR Newswire
13/09/2023

Voting Rights and Shares Capital of the Company

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDateNumber of Shares OutstandingTotal number of voting rightsTotal voting rights, theoretical 1 Total voting rights,...
Nasdaq GlobeNewswire
13/09/2023

Jazz Pharmaceuticals to Participate in Three Upcoming Investor Conferences

2023 Cantor Fitzgerald Global Healthcare Conference 2023 Cantor Fitzgerald Global Healthcare Conference BofA Securities 2023 CNS Therapeutics Virtual Conference Live webcasts, where applicable, may be accessed via the Investors section of the Jazz Pharmaceuticals website atwww.jazzpharmaceuticals.com. A replay of the webcasts will be archived on the website for 30 days. About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company...
PR Newswire
13/09/2023

OKYO Pharma Announces Public Offering of Ordinary Shares

LONDON and NEW YORK, Sept.13, 2023(GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED”), today announced that it intends to offer to sell its ordinary shares in an underwritten public offering (the “Offering”). All of the ordinary shares are to be sold by the Company. The Company expects to grant the underwriter a 30-day option to purchase up to an...
Nasdaq GlobeNewswire
13/09/2023

Annual Report 2022/23 - Continued solid earnings, but weaker growth amid…

ANNOUNCEMENT NO . 243 13 September 2023 Annual Report 2022/23 (1 July 2022 - 30 June 2023)Continued solid earnings, but weaker growth amid challenging market conditions ChemoMetec's revenue for 2022/23 grew by 4% to DKK 442.3 million and operating profit (EBITDA) for 2022/23 was DKK 251.0 million, a 13% increase on 2021/22. In 2022/23, ChemoMetec continued developing the new Xcyto platform and the instruments XcytoMatic 40 and XcytoMatic 30. In addition...
Nasdaq GlobeNewswire
13/09/2023

Guidance for the 2023/24 financial year

ANNOUNCEMENT NO . 242 13 September 2023Guidance for the 2023/24 financial yearChemoMetec has today approved the annual report for 2022/23, including the guidance for 2023/24, which is considered inside information.For 2023/24, ChemoMetec expects revenue in the range of DKK 400-435 million (2022/23: DKK 442.3 million) and EBITDA in the range of DKK 200-220 (2022/23: DKK 251.0 million).The annual report for 2022/23, which is released along with this announcement, sets out the...
Nasdaq GlobeNewswire
13/09/2023

Countertop Market Projected to Reach $163.37 Billion by 2028, Engineered Quartz…

Browse In-Depth TOC on the Countertop Market Browse In-Depth TOC on the Countertop Market 44 – Tables 66 – Charts 215 – Pages The growing use of countertops in various applications, including modular kitchens and stylish bathroom shelves for luxury settings, highlights their increasing importance in both residential and commercial sectors. Leading countertop manufacturers are responding to the rising demand for engineered and natural stone materials in...
PR Newswire
13/09/2023

ONWARD® Launches Partnership with Service-Disabled Veteran-Owned Business to…

Agreement with Lovell provides rapid access to US Veterans Health Administration and US Department of Defense Military Health System The two-year distribution agreement provides ONWARD access to the United States Veterans Health Administration, the world's largest healthcare system providing spinal cord injury care, and the US Department of Defense Military Health System, the world's largest military healthcare provider. Under the agreement, Lovell will add ONWARD therapies to its relevant...
Nasdaq GlobeNewswire
13/09/2023

Novo Nordisk A/S - share repurchase programme

Bagsværd , Denmark, 13September 2023– On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023...
Nasdaq GlobeNewswire
13/09/2023

Advance Directives Market worth $291.1 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227199224 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227199224 Browse in-depth TOC on "Advance Directives Market" 120 - Tables 120 - Figures 67 - Pages Advance Directives Market Scope: Healthcare Providers segment is expected to register the substantial share by end user of advance directives market The healthcare...
PR Newswire
13/09/2023

Therabody Doubles Down in Beauty Launching TheraFace Mask

The new product innovation, TheraFace Mask, is an FDA cleared, powerful and effective LED light therapy mask that is clinically proven to reduce signs of aging, firm skin and increase radiance. The mask's 648 Red, Red + Infrared and Blue LED lights—three times more than the leading competitor—provide full-face coverage with added vibration therapy that Therabody has perfected and patented for improved relaxation. The new product innovation, TheraFace Mask, is an FDA cleared, powerful and...
PR Newswire
13/09/2023

The opportunity within the Cell Therapy Manufacturing Market to grow at 12% CAGR…

Over the years, several advanced and innovative automation tools and technologies have been developed; these have been demonstrated to hold the potential for significant reduction in the cost associated with the manufacturing of advanced therapy medicinal products (such as cell therapy manufacturing), thereby, making such products more affordable. One such emerging concept, namely GMP-In-A Box, offers several advantages, including increased throughput, decreased idle time between batch runs and…
PR Newswire
13/09/2023

Blood Culture Test Market to Gain Massive Growth Opportunities by 2029-…

Brandessence Market Research has recently curated a report on Blood Culture Test Market with an aim to equip businesses with comprehensive insights about this industry. The growth drivers, restraints, opportunities, and challenges of this market are well elaborated in this study. It also offers a 360-degree outlook of the top market segments and geographical landscape with accurate growth projections of each region, country, and niche segments. Apart from that, it highlights each player…
PR Newswire
13/09/2023

Ringworm Disease: Market Insight Epidemiology , Forecast , Prevention…

Diagnostic Analysis Diagnostic Analysis Diagnosing ringworm accurately is the crucial first step toward effective 3 day ringworm treatment. Traditional diagnostic techniques are the backbone of this process. Conventional Diagnostic Techniques Healthcare providers often rely on their expertise to visually inspect and diagnose ringworm based on characteristic symptoms. These symptoms include a red, circular rash with raised edges and itching. However, visual diagnosis alone may not...
PR Newswire
13/09/2023

Revolutionizing Pneumonia Disease Care: Innovative Market Entry Strategies &…

It is worth noting that the emergence of the COVID-19 pandemic has had a significant impact on the pneumonia disease landscape. Symptoms of Coronavirus infection is quite similar to that of Pneumonia. During the course of the pandemic, it was discovered that individuals with severe COVID-19 infection often showed signs of pneumonia. It is worth noting that the emergence of the COVID-19 pandemic has had a significant impact on the pneumonia disease landscape. Symptoms of Coronavirus infection…
PR Newswire
13/09/2023

Colorectal Cancer Market to Garner Substantial Revenue by 2029- Brandessence…

Brandessence Market Research has recently published a report on the Colorectal Cancer Market. This report has been specifically rendered with an aim to help businesses to get an in depth overview of the industry's crucial aspects. The growth drivers, opportunities, challenges, and restraints well elucidated in this study. Apart from that, the top segments and geographies are thoroughly evaluated with an aim to determine the scope and size of this business sphere. The study further sheds light on…
PR Newswire
13/09/2023

Biotechnology Contract Manufacturing Market worth $24.8 billion |…

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163964739 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163964739 Browse in-depth TOC on "Biotechnology Contract Manufacturing Market" 287 - Tables 48 - Figures 336 - Pages Biotechnology Contract Manufacturing Market Scope: The monoclonal antibody segment accounted for the largest share by molecule type in the biotechnology...
PR Newswire
13/09/2023

BBS-Bioactive Bone Substitutes Plc – Insider information: Plan to complete minor…

BBS-Bioactive Bone Substitutes Plc, Company announcement, Insider information, 13 September 2023 at 4:45 p.m.BBS-Bioactive Bone Substitutes Plc – Insider information: Plan to complete minor open issues approved – the Company updates its outlook on the schedule of the CE marking The CE marking process of BBS-Bioactive Bone Substitutes Plc's ("BBS") first product (ARTEBONE® Paste) includes two main streams: approval of the quality system and approval of the product.Regarding the...
Nasdaq GlobeNewswire
13/09/2023

Curia Supports Replicate Bioscience's Phase 1 Clinical Trial of Novel…

Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA) Curia conducted process development, scale-up and cGMP manufacture of srRNA RBI-4000 drug substance. At approximately 10,000 bases, this srRNA is significantly larger than a conventional linear mRNA and has been historically difficult to manufacture at the scales required for clinical development. Curia's analytical method development and qualification of...
Nasdaq GlobeNewswire
13/09/2023

Wearable Sensors Can be Valuable Assets on the Weight Loss Journey

Using a remote patient monitoring program to continuously track a patient's well-being can go a long way in helping to prevent weight gain progression and life-threatening medical complications, in addition to helping the patient lose weight. Traditionally, patient monitoring devices are used in hospitals to monitor a patient's vital signs. Nowadays, with the advancements in wireless technology, these devices can be used to monitor a patient's various physiological parameters remotely. In…
PR Newswire
13/09/2023

Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into…

Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC) closed out 2022 on a high note, having received notice of FTD for its flagship asset, pelareorep, a first-in-class intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc.(NASDAQ:ONCY) (TSX:ONC) closed out 2022 on a high note, having received notice of FTD for its flagship asset, pelareorep, a first-in-class intravenously delivered immunotherapeutic agent for the...
PR Newswire
13/09/2023
Altri  Comunicati